NCT00191074View on ClinicalTrials.gov

Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

PHASE3CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

January 31, 2006

Conditions
Growth Disorder
Interventions
DRUG

somatropin, rDNA origin, for injection

Trial Locations (1)

20892

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bethesda

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191074 - Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature | Biotech Hunter | Biotech Hunter